Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

NCT00304993 is registered in ClinicalTrials.gov with Foundation Research, Florida as lead sponsor.

NCT NCT00304993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00304993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
Lead sponsor
Foundation Research, Florida
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2001
Completion date
February 28, 2005
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome x